Assyro AI
Orange Book product · Brand (NDA)

Acetaminophen

Acetaminophen

Brand (NDA)NDA 204957TE AP2RLD B Braun Medical
Approved
Feb 18, 2021
Application
Brand (NDA)
TE code
AP2
Listed patents
0
Acetaminophen (Acetaminophen) is B Braun Medical's brand-name drug, approved by the FDA under NDA 204957 in 2021. It is a reference-listed drug (RLD) — the approved product that generic ANDA applicants must show their version is equivalent to. Its therapeutic-equivalence code is AP2, so the FDA considers it substitutable for the reference brand. 29 approved generics share this drug's active ingredient.

Sourced from the FDA Orange Book

Approval, patents, exclusivity

Key dates

Key dates

  1. Approval

    FDA approval date of this drug product.

    Feb 18, 2021

    5 yr 6 mo ago

  2. Today

FDA product record

Pharmaceutical detail

Pharmaceutical detail

Active ingredient

ACETAMINOPHEN

Strength

1GM/100ML (10MG/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

AP2

Application

NDA 204957

Product number

002

Marketing status

Prescription

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Same application

Other strengths in NDA 204957

Brand + generics

Active-ingredient family

Orange Book patent file

Listed patents

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Acetaminophen — frequently asked questions

Approval, therapeutic equivalence, patents, and exclusivity for this product, from the FDA Orange Book.

Built directly from the FDA Orange Book data file. This product page links back to the Acetaminophen active-ingredient family, which is the canonical reference for generics, patents, and exclusivity across all strengths.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.